Does Stress Change EEG Measures in Students: A Feasibility Study (EEG_stress)

November 27, 2024 updated by: Alice Cade, Scotland College of Chiropractic

Does Stress Change EEG Measures in Students: A Feasibility Study.

Psychological stress is a frequent human affection and has a considerable impact on modern society, and tertiary-level students often report increased stress levels as the semester progresses. While many questionnaires assess psychological stress, they do not capture objective data. Much research has shown that electroencephalography (EEG) can capture objective markers of stress, and recent studies have shown that EEG can even classify stress levels.

This study aims to assess the feasibility of using EEG to objectively assess stress over the course of a semester of work in chiropractic students engaged in a Masters level course in Scotland.

Study Overview

Status

Recruiting

Detailed Description

The study's primary aim is to assess the feasibility of a more extensive future study. The investigators also hypothesise that as the semester progresses, participants will exhibit changes in their EEG outcomes that may be related to longitudinal or direct stressors.

Study design and setting This study will be an observational study with a stress-related questionnaire (Depression, Anxiety, and Stress Scale - 21 (DASS-21)) over three time-points.

Participants The investigators aim to recruit 10 participants and assess them three times over the course of their semester, early, middle, and late semester, with at least a four-week gap between each data collection. The investigators aim to recruit only healthy Scottish chiropractic students with no prior diagnosed mental disorder and who are capable of understanding the study procedure.

Procedure Following screening for eligibility and consent, i.e., visit one (baseline), participants will be asked to answer a questionnaire and undergo EEG measurement and Montreal imaging stress task (MIST). The same EEG and questionnaire procedure will be performed in the remaining two data collection sessions.

Each EEG recording session, with the participant seated, will consist of a two-minute resting state with the eyes closed for a baseline relaxation level among the participants. A following two-minute eyes-open phase will take place. After which, participants will be asked to perform the experimental phase of the MIST task, a following two-minute recording phase will be with the eyes open, and a final two-minute resting phase with eyes closed will conclude the task.

The investigators aim to conclude the data collection around 16 weeks after the initial participant is recruited.

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Scottish chiropractic college students

Description

Inclusion Criteria:

Healthy Scottish chiropractic students with no prior diagnosed mental disorder and who are capable of understanding the study procedure.

Exclusion Criteria:

A pre-diagnosed mental health disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
SCC students
Healthy adults attending and actively enrolled in the Scotland College of Chiropractic's degree program and who were without health issues or mental disorders.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility recruitment rates
Time Frame: 0, 6, 12 weeks
recruitment rates - how many people were recruited ove rthe study time period
0, 6, 12 weeks
Feasibility - retention
Time Frame: 0, 6, 12 weeks
Participant retention - how many participants completed the full study
0, 6, 12 weeks
Feasibility - queries
Time Frame: 12 weeks
queries from participants - how many question did participants ask and were they answerable
12 weeks
Feasibility - ease
Time Frame: 12 weeks
Ease of data collection - was the data collection procedure manageable for the investigator
12 weeks
Feasibility - Adverse
Time Frame: 12 weeks
Adverse events - were any adverse events either minor or significant, recorded at any time throughout the trial
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electroencephalogram recordings
Time Frame: 12 weeks
Power spectra between 1 and 80 Hz (using the Fourier basis with a 2 s wide Hanning window) will be calculated based on clean data from all sensors (electrodes).
12 weeks
Electroencephalogram recordings
Time Frame: 12 weeks
The average power of each classical frequency band (delta (1-4 Hz), theta (4.1-8 Hz), alpha (8.1-12 Hz), beta (12.1-32 Hz), and gamma (32.1-80 Hz). These measures will be used to test for differences in basic EEG parameters across conditions (rest, Montreal Imaging Stress Task (MIST)) and groups (early, middle and late timepoints), as well as for correlations with key demographic and clinical variables.
12 weeks
Electroencephalogram recordings
Time Frame: 12 weeks
Time Frequency Analysis: For EEG data acquired during the Montreal Imaging Stress Task (MIST), we will also quantify continuous changes in power of EEG frequency bands as a function of time (i.e., prior to, during and after the Montreal Imaging Stress Task (MIST)).
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression, Anxiety, and Stress Scale - 21 (DASS-21)
Time Frame: 12 weeks

The DASS 21 is a 21-item self-report questionnaire designed to measure the severity of a range of symptoms common to both Depression and Anxiety. In completing the DASS, the individual is required to indicate the presence of a symptom over the previous week. Each item is scored from 0 (did not apply to me at all over the last week) to 3 (applied to me very much or most of the time over the past week).

The DASS subscores Depression: ranges from 0-9 (normal) to 28+ (extremely severe depression) Anxiety: Ranges from 0-7 (normal) to 20+ (extremely severe anxiety) Stress: Ranges from 0-14 (normal) to 34+ (extremely severe stress)

12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alice Cade, BSc, BSc(chiro), MHSc, PhD, Scotland College of Chiropractic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2024

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

September 12, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 10, 2024

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 348503

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Upon reasonable request, anonymised post-process eeg data will be made available

IPD Sharing Time Frame

01/10/2024 for up to two years (01/10/2026)

IPD Sharing Access Criteria

Other researchers Via emailing the chief investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Subscribe